Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits. - sprookjes - yvandenbroek - TriplyDB

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

http://www.wikidata.org/entity/Q27687469

about

Protection from genetic diathesis in attention-deficit/hyperactivity disorder: possible complementary roles of exercise.Toxicological profile of ultrapure 2,2',3,4,4',5,5'-heptachlorbiphenyl (PCB 180) in adult rats.Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.Diagnosis of children's attention deficit hyperactivity disorder (ADHD) and its association with cytomegalovirus infection with ADHD: a historical review Sustained Modafinil Treatment Effects on Control-Related Gamma Oscillatory Power in Schizophrenia.Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/hyperactivity disorder Sarcosine treatment for oppositional defiant disorder symptoms of attention deficit hyperactivity disorder children.New directions for therapeutics in ADHD.Genetic polymorphisms of DAT1 and COMT differentially associate with actigraphy-derived sleep-wake cycles in young adults.Modafinil augments oscillatory power in middle frequencies during rule selection.Phenylephrine enhances glutamate release in the medial prefrontal cortex through interaction with N-type Ca2+ channels and release machinery.

P2860

Q22252417-35C3017D-ACD9-4872-AFC1-0448A5C78E38 Q34066362-B0E741BE-E39C-452E-8574-9C878D4F923C Q34257043-85A0D0D9-B125-4C67-BDA1-7F10888C1B5F Q34475309-6D533313-93F9-474A-9E91-B1D43371DD09 Q36183375-8D969249-1ADC-4282-89FD-A23E7750982D Q36690640-43E82315-83A8-4084-B02E-3CD9C78380FF Q37624913-6C52C335-E92F-48A6-B5B4-2630B064F0FB Q38839164-FA8F79A2-86CD-432F-8938-EE22875F60BA Q42262533-68630AAE-C8ED-41DC-AB6C-84658118FF91 Q43754658-2CE822E8-2A98-44AC-B960-C4A0AF5A9BF3 Q44306243-7D75554A-0348-404D-B22F-61E1974D11D2 Q48559433-5934CC90-7CF2-47C8-85AC-826A18E41A76

P2860

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

http://www.wikidata.org/entity/Q27687469

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

@ast

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

@en

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

@nl

type

label

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

@ast

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

@en

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

@nl

prefLabel

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

@ast

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

@en

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

@nl

P1433

Q27687469-972ADD7F-3423-4AC3-9C24-0C0031B3BE7B

P1476

Q27687469-A5A64155-E77F-461D-ABFD-EC6BB1ACFD54

P2093

Q27687469-44EBA5FA-E570-40DA-AD48-DF25A22D4D66

P2860

Q27687469-05308EEF-B57C-493D-A8CC-3736FD678B89

Q27687469-06ED4008-7C8C-4604-9973-B17EFD34F7F9

Q27687469-08436B72-682B-43B9-9491-150F69795EE9

Q27687469-08CDA7E6-C50C-4571-9C2E-541910F74DA4

Q27687469-08D70555-914A-4EF2-A1E5-012E1523DDB7

Q27687469-090001FD-98EC-4DFE-836E-6B4FE8345E05

Q27687469-0C7014B6-92C5-48A6-AFC3-E428D8242118

Q27687469-0DDEA376-1D42-4719-AC1B-4A04CA6E9AD9

Q27687469-0F8134EB-8ADF-4BFF-9C2E-A3F078638FD1

Q27687469-10A30A68-0BAC-446A-875E-48D819817B20

P2888

Q27687469-4EF329E1-A915-47F7-80AA-91B340511490

P304

Q27687469-A1CF7151-756B-4DDC-B3F2-74F0AD886A3A

P31

Q27687469-4591ED24-D85C-4AB3-8B28-C5E7B358E916

P356

Q27687469-81EADB94-D31F-4885-B833-7A9053E2D9C1

P433

Q27687469-AB6ABEA3-52BA-4546-87B6-7B5993B426FE

P478

Q27687469-76940F80-D76F-4B1C-A1A5-FD8468FF5C79

P577

Q27687469-1170096D-2524-4B61-A99B-FE4E8247ECF2

P6179

Q27687469-6FAF9C83-5A2C-4E94-85C0-B9DD59948C20

P698

Q27687469-4AAA20C2-7FD0-4A33-BD4A-9271E17F1046

P921

Q27687469-06DE68EA-EEA6-41C9-AAE2-367ACE89E48F

Q27687469-464260DC-0306-40BB-8790-BD6C7622473F

Q27687469-BCD2BDAE-016C-42E3-93D6-9FA075EE3A5A

P932

Q27687469-8EC28B7D-0AD6-4311-ACDF-1A2CDB2A0AF7

P356

S13311-012-0128-7

P1433

Neurotherapeutics

P1476

Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits.

@en

P2093

Michael J. Minzenberg

http://www.w3.org/2001/XMLSchema#string

P2860

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents

Striatal Dopamine Transporter Alterations in ADHD: Pathophysiology or Adaptation to Psychostimulants? A Meta-Analysis

Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects

The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

3-Year Follow-up of the NIMH MTA Study

Cognitive enhancers for the treatment of ADHD

Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder

Evaluating dopamine reward pathway in ADHD: clinical implications

Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism

P2888

s13311-012-0128-7

P304

610-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-012-0128-7

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1041048035

http://www.w3.org/2001/XMLSchema#string

P698

22718077

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder

pharmacotherapy

P932

3441935

http://www.w3.org/2001/XMLSchema#string